New antitumor and antiangiogenic heterocyclic compounds: Synthesis, molecular modeling, screening of enzymatic inhibition and studies in tumor and endothelial cell lines with tyrosine kinase membrane receptors as targets.
Citação norma ChicagoNew Antitumor and Antiangiogenic Heterocyclic Compounds: Synthesis, Molecular Modeling, Screening of Enzymatic Inhibition and Studies in Tumor and Endothelial Cell Lines with Tyrosine Kinase Membrane Receptors as Targets.
Citação norma MLANew Antitumor and Antiangiogenic Heterocyclic Compounds: Synthesis, Molecular Modeling, Screening of Enzymatic Inhibition and Studies in Tumor and Endothelial Cell Lines with Tyrosine Kinase Membrane Receptors as Targets.